| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2084001 | European Journal of Pharmaceutics and Biopharmaceutics | 2012 | 6 Pages |
Abstract
Polymeric nanoparticles are emerging as an attractive treatment options for cancer due to their favorable size distribution, drug carrying capacity, and tunable properties. In particular, intelligent nanoparticles that respond to biological cues are of interest because of their ability to provide controlled release at a specific site. Tumor sites display abnormal pH profiles and pathophysiology that can be exploited to provide localized release. In this expert opinion, we discuss passive and active targeting of nanoparticles and several classes of pH-responsive nanoparticles.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
William B. Liechty, Nicholas A. Peppas,